TERT-CLPTM1L Polymorphism rs401681 Contributes to Cancers Risk: Evidence from a Meta-Analysis Based on 29 Publications

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Yin, Jieyun ^a   Li, Yangkai ^a   Yin, Ming ^b   Sun, Jingwen ^a   Liu, Li ^a   Qin, Qin ^a   Li, Xiaorong ^a   Long, Lu ^a   Nie, Shaofa ^a   Wei, Sheng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b GEISINGER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; ASIAN; BASAL CELL CARCINOMA; BLADDER CANCER; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; GENETIC VARIABILITY; GENOTYPE; GLIOBLASTOMA; HUMAN; LUNG CANCER; MELANOMA; META ANALYSIS; MULTIPLE MYELOMA; OVARY CANCER; PANCREAS CANCER; PROSTATE CANCER; PUBLICATION; RISK FACTOR; SAMPLE SIZE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; TERT CLPTM1L GENE; TUMOR GENE;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS; POLYMORPHISM, GENETIC; TELOMERASE;

EID: 84870622476     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050650     Document Type: Article

References (76)

1. Olovnikov AM, (1971) [Principle of marginotomy in template synthesis of polynucleotides]. Dokl Akad Nauk SSSR 201: 1496-1499.
2. Chudnovsky Y, Adams AE, Robbins PB, Lin Q, Khavari PA, (2005) Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet 37: 745-749.
3. Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, et al. (2010) Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 70: 3170-3176.
4. Greider CW, Blackburn EH, (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413.
5. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279: 349-352.
6. De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, et al. (2009) A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 18: 1152-1156.
7. Zee RY, Castonguay AJ, Barton NS, Buring JE, (2009) Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol Biomarkers Prev 18: 2280-2282.
8. Baird DM, (2010) Variation at the TERT locus and predisposition for cancer. Expert Rev Mol Med 12: e16.
9. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y, (2001) A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis. Biochem Biophys Res Commun 280: 1148-1154.
10. Zienolddiny S, Skaug V, Landvik NE, Ryberg D, Phillips DH, et al. (2009) The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung. Carcinogenesis 30: 1368-1371.
11. Wang S, Hu C, Zhu J, (2007) Transcriptional silencing of a novel hTERT reporter locus during in vitro differentiation of mouse embryonic stem cells. Mol Biol Cell 18: 669-677.
12. Asakura T, Imai A, Ohkubo-Uraoka N, Kuroda M, Iidaka Y, et al. (2005) Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma. Oncol Rep 14: 601-607.
13. Rafnar T, Sulem P, Stacey SN, Geller F, Gudmundsson J, et al. (2009) Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet 41: 221-227.
14. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, et al. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
15. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85: 679-691.
16. Hsu CP, Hsu NY, Lee LW, Ko JL, (2006) Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter-effect on telomerase expression and telomere length maintenance in non-small cell lung cancer. Eur J Cancer 42: 1466-1474.
17. Carpentier C, Lejeune J, Gros F, Everhard S, Marie Y, et al. (2007) Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol 84: 249-253.
18. Truong T, Hung RJ, Amos CI, Wu X, Bickeboller H, et al. (2010) Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst 102: 959-971.
19. Yoon KA, Park JH, Han J, Park S, Lee GK, et al. (2010) A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet 19: 4948-4954.
20. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, et al. (2009) A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet 85: 679-691.
21. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, et al. (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41: 899-904.
22. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, et al. (2010) A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 42: 224-228.
23. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, et al. (2008) Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 40: 1407-1409.
24. Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, et al. (2009) New common variants affecting susceptibility to basal cell carcinoma. Nat Genet 41: 909-914.
25. Pooley KA, Tyrer J, Shah M, Driver KE, Leyland J, et al. (2010) No association between TERT-CLPTM1L single nucleotide polymorphism rs401681 and mean telomere length or cancer risk. Cancer Epidemiol Biomarkers Prev 19: 1862-1865.
26. Kanetsky PA, Mitra N, Vardhanabhuti S, Vaughn DJ, Li M, et al. (2011) A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Hum Mol Genet 20: 3109-3117.
27. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
28. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
29. Thompson SG, Sharp SJ, (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18: 2693-2708.
30. Thompson SG, Smith TC, Sharp SJ, (1997) Investigating underlying risk as a source of heterogeneity in meta-analysis. Stat Med 16: 2741-2758.
31. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
32. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N, (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.
33. Liu P, Vikis HG, Lu Y, Wang Y, Schwartz AG, et al. (2010) Cumulative effect of multiple loci on genetic susceptibility to familial lung cancer. Cancer Epidemiol Biomarkers Prev 19: 517-524.
34. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, et al. (2011) Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet 43: 1108-1113.
35. Shimizu M, Kiyotani K, Kunitoh H, Kamataki T, Yamazaki H, (2011) Different effects of TERT, TP63, and CYP2A6 polymorphism on individual risk of tobacco-related lung cancer in male Japanese smokers. Journal of Cancer Therapy 2: 690-697.
36. Kiltie AE, (2010) Common predisposition alleles for moderately common cancers: bladder cancer. Curr Opin Genet Dev 20: 218-224.
37. Helfand BT, Kan D, Modi P, Catalona WJ, (2011) Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination. Prostate 71: 394-402.
38. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nature Genetics 40: 1404-1406.
39. Song W, Ruder AM, Hu L, Li Y, Ni R, et al. (2009) Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs. PLoS One 4: e7157.
40. Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, et al. (2010) Genetic Correction of PSA Values Using Sequence Variants Associated with PSA Levels. Science Translational Medicine 2.
41. Kohno T, Kunitoh H, Shimada Y, Shiraishi K, Ishii Y, et al. (2010) Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes. Carcinogenesis 31: 834-841.
42. Liu Z, Li G, Wei S, Niu J, Wang LE, et al. (2010) Genetic variations in TERT-CLPTM1L genes and risk of squamous cell carcinoma of the head and neck. Carcinogenesis 31: 1977-1981.
43. Miki D, Kubo M, Takahashi A, Yoon KA, Kim J, et al. (2010) Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet 42: 893-896.
44. Prescott J, McGrath M, Lee IM, Buring JE, De Vivo I, (2010) Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer 116: 4275-4282.
45. Rothman N, Garcia-Closas M, Chatterjee N, Malats N, Wu X, et al. (2010) A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet 42: 978-984.
46. Turnbull C, Rapley EA, Seal S, Pernet D, Renwick A, et al. (2010) Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 42: 604-607.
47. Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, et al. (2011) Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. PLoS One 6: e24987.
48. Gago-Dominguez M, Jiang X, Conti DV, Castelao JE, Stern MC, et al. (2011) Genetic variations on chromosomes 5p15 and 15q25 and bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study. Carcinogenesis 32: 197-202.
49. Hu Z, Wu C, Shi Y, Guo H, Zhao X, et al. (2011) A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 43: 792-796.
50. Nan H, Qureshi AA, Prescott J, De Vivo I, Han J, (2011) Genetic variants in telomere-maintaining genes and skin cancer risk. Hum Genet 129: 247-253.
51. Pande M, Spitz MR, Wu X, Gorlov IP, Chen WV, et al. (2011) Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk. Carcinogenesis 32: 1493-1499.
52. Rizzato C, Campa D, Giese N, Werner J, Rachakonda PS, et al. (2011) Pancreatic cancer susceptibility Loci and their role in survival. PLoS One 6: e27921.
53. Bae EY, Lee SY, Kang BK, Lee EJ, Choi YY, et al. (2012) Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population. Respirology.
54. Chen XF, Cai S, Chen QG, Ni ZH, Tang JH, et al. (2012) Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma. Genet Mol Res 11: 370-378.
55. Klein RJ, Hallden C, Gupta A, Savage CJ, Dahlin A, et al. (2012) Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men. Eur Urol 61: 471-477.
56. Ma Z, Hu Q, Chen Z, Tao S, Macnamara L, et al. (2012) Systematic evaluation of bladder cancer risk-associated single-nucleotide polymorphisms in a Chinese population. Mol Carcinog.
57. Willis JA, Olson SH, Orlow I, Mukherjee S, McWilliams RR, et al. (2012) A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival. Clin Cancer Res 18: 3942-3951.
58. Zheng Y, Ogundiran TO, Adebamowo C, Nathanson KL, Domchek SM, et al. (2012) Lack of association between common single nucleotide polymorphisms in the TERT-CLPTM1L locus and breast cancer in women of African ancestry. Breast Cancer Res Treat 132: 341-345.
59. Palomaki GE, Melillo S, Bradley LA, (2010) Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA 303: 648-656.
60. Koushik A, Platt RW, Franco EL, (2004) p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13: 11-22.
61. Voils CI, Crandell JL, Chang Y, Leeman J, Sandelowski M, (2011) Combining adjusted and unadjusted findings in mixed research synthesis. J Eval Clin Pract 17: 429-434.
62. Harder T, Bergmann R, Kallischnigg G, Plagemann A, (2005) Duration of breastfeeding and risk of overweight: a meta-analysis. Am J Epidemiol 162: 397-403.
63. Wick M, Zubov D, Hagen G, (1999) Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene 232: 97-106.
64. Bagheri S, Nosrati M, Li S, Fong S, Torabian S, et al. (2006) Genes and pathways downstream of telomerase in melanoma metastasis. Proc Natl Acad Sci U S A 103: 11306-11311.
65. Nosrati M, Li S, Bagheri S, Ginzinger D, Blackburn EH, et al. (2004) Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clin Cancer Res 10: 4983-4990.
66. Colombo J, Fachel AA, De Freitas Calmon M, Cury PM, Fukuyama EE, et al. (2009) Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma. Oncol Rep 21: 649-663.
67. Han J, Qureshi AA, Prescott J, Guo Q, Ye L, et al. (2009) A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 129: 415-421.
68. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, et al. (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40: 1404-1406.
69. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, et al. (2001) Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 98: 12683-12688.
70. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, et al. (2003) Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 95: 1211-1218.
71. Bataille V, Kato BS, Falchi M, Gardner J, Kimura M, et al. (2007) Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo. Cancer Epidemiol Biomarkers Prev 16: 1499-1502.
72. Mooi WJ, Peeper DS, (2006) Oncogene-induced cell senescence-halting on the road to cancer. N Engl J Med 355: 1037-1046.
73. Xu Z, Taylor JA, (2009) SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 37: W600-605.
74. Hancock DB, Scott WK (2007) Population-based case-control association studies. Curr Protoc Hum Genet Chapter 1: Unit 1 17.
75. Szklo M, (1998) Population-based cohort studies. Epidemiol Rev 20: 81-90.
76. Colditz GA, Burdick E, Mosteller F, (1995) Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 142: 371-382.